DHGWA
NVO

Dixon Hughes Goodman Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$79K Sell
1,428
-18
-1% -$924 0.02% 266
2021
Q4 		$81K Buy
+1,446
New +$78.3K 0.03% 223

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's NVO Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors reduced its Novo Nordisk (NVO) stake by 1.2% in Q1 2022, selling an estimated $924 and leaving 1,428 shares worth $79K. The position accounts for 0.02% of the portfolio, ranked #266.

Dixon Hughes Goodman Wealth Advisors first reported a position in NVO in Q4 2021 and has held it in 2 quarters since. The position peaked at $81K in Q4 2021. 902 funds tracked by Wall St. Rank hold NVO as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 1,428 shares of Novo Nordisk worth $79K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors sold 18 Novo Nordisk shares in Q1 2022, an estimated $924.
  • Novo Nordisk made up 0.02% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #266 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in Novo Nordisk in Q4 2021 and has held it in 2 quarters since.
  • Dixon Hughes Goodman Wealth Advisors's Novo Nordisk position peaked at $81K in Q4 2021.
  • 902 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.